Depict Medical Imaging LLC is categorized under X-Ray Equipment Manufacturers in Englewood, CO and active since 2004.
Depict Medical Imaging LLC was established in 2004, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a X-Ray Equipment Manufacturers business, which does work in the B2B market, and is classified as a X-Ray Equipment Manufacturers, under code number 334517 by the NAICS.
If you are seeking more information, feel free to contact Paul Krzystyniak at the company’s single location by writing to 3720 South Lipan St # A, Englewood, Colorado CO 80110 or by phoning (303) 761-0131. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Depict Medical Imaging LLC |
Contact Person: | Paul Krzystyniak |
Address: | 3720 South Lipan St # A, Englewood, Colorado 80110 |
Phone Number: | (303) 761-0131 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | X-Ray Equipment Manufacturers |
SIC Code: | 3844 |
NAICS Code: | 334517 |
Share This Business: |
Depict Medical Imaging LLC was started in 2004 to provide professional X-Ray Equipment Manufacturers under the SIC code 3844 and NAICS code 334517. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Paul Krzystyniak for inquiries that concern Depict Medical Imaging LLC by calling the company number (303) 761-0131, as your correspondence is most welcome. Additionally, the physical location of the single location of Depict Medical Imaging LLC can be found at the coordinates 39.648898,-105.001518 as well as the street address 3720 South Lipan St # A in Englewood, Colorado 80110.
For its online presence, you may visit Depict Medical Imaging LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.